Welcome to Cisterna's Resources hub. RNA research moves fast and we're here to help you stay ahead of it. Browse technical articles, company news, product spotlights, industry updates and practical guides covering everything from RNA purity and synthesis to the latest advances in mRNA and non-coding RNA applications.
Cisterna Biologics has successfully completed its NSF SBIR Phase I project, demonstrating for the first time that yeast-engineered mRNA can be selectively purified and drive protein expression in human cells, laying the groundwork for a more scalable, cost-efficient approach to non-immunogenic mRNA manufacturing.
We're excited to launch Cisterna's blog, a space for RNA researchers, scientists, and biotech enthusiasts to explore the science, applications, and latest developments in RNA research.
Not all RNAs are created equal. Length impurities generated during standard synthesis can silently compromise certain applications. Here's what you need to know and why it matters for your research and development.